Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation
Atrial fibrillation (AF) is the main cause of cardioembolic ischemic stroke (IS), it occurs in 25–35% of patients with IS, and its presence increases the risk of recurrent stroke compared with patients with sinus rhythm. The main method of preventing recurrent IS in AF is the administration of oral...
Main Authors: | O. D. Ostroumova, T. M. Ostroumova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-06-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1830 |
Similar Items
-
Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01) -
Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
by: Jin-Yi Hsu, et al.
Published: (2022-07-01) -
Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies
by: V.A. Parfenov, et al.
Published: (2014-10-01) -
Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
by: Jovanović Dejana R.
Published: (2020-01-01) -
Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation—A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation
by: David Z. Rose, et al.
Published: (2019-09-01)